UNSPSC 51142520: Budipine

This classification denotes a cation channel blocker and antiparkinsonian agent with the molecular formula C21H27N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L9026OPI2Z, chemically known as 1-tert-butyl-4,4-diphenylpiperidine but generally known as budipine, which bears US NIH Compound Identifier 68778. Budipine most often comes in base and hydrochloride forms. European Medicines Agency schedules Budipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05956MIG.

UNSPSC 51142520 Budipine is a Commodity code that does not reflect the work actually being solicited under it in recent state and local procurement. The single recent opportunity tagged to this code—Seminole County, Florida's IFB 60459723LAS—sought naloxone and safe drug deactivation systems, products unrelated to budipine's pharmaceutical scope. The county's procurement was designed to support community health initiatives with quarterly deliveries of 1,900 units of naloxone and 800 deactivation systems annually to the Seminole County Community Health Building in Sanford, with electronic bidding through the county's e-Procurement Portal and compliance requirements including drug-free workplace certification and E-Verify authorization.

The code shows minimal relevant recent activity. Beyond the Seminole County opportunity, no other state or local solicitations under UNSPSC 51142520 appear in the available record. The single posting does not establish a pattern of issuing-body mix or geographic concentration. Bidders interested in this code should treat the present taxonomy assignment as potentially misaligned with actual procurement demand and monitor whether future opportunities under 51142520 reflect budipine or continue to route unrelated pharmaceutical products through the same code number.